TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
BIOA

BioAge Labs, Inc

Healthcare · Drug Manufacturers - Specialty & Generic · —

7.90$ -6.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement BIOA
Line item 2013 2014 2015 2016 2017 2022 2023 2024 2025
– -42.1% +40.8% +280.9% +80.6% -100.0% – – –
– +124.8% -56.8% +423.1% +63.3% – – – –
– – – – – – – – –
– -8.6% +33.8% -64.5% -24.0% +458.3% +11.0% +74.2% +25.3%
– +22.8% +6.8% -0.7% +59.1% -9.3% +53.6% +32.0% +45.2%
– -25.4% +24.0% -36.4% +323.5% -61.1% +21.1% +61.6% +30.2%
– – – – – – – – –
– – – – – – +3,134.0% -69.6% -70.6%
– – – – – – – – –
– -26.7% -105.0% – +218.7% +194.9% +3,134.0% -1,012.4% –
– – – – – – – – –
– – – – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?